El grup de l’investigador ICREA Xavier Trepat, a l’Institut de Bioenginyeria de Catalunya (IBEC), juntament amb investigadors de la Universitat Politècnica de Catalunya – BarcelonaTech (UPC) i del Centre Internacional de Mètodes Numèrics a l’Enginyeria (CIMNE), està aprenent a controlar aquestes forces i programar la forma d’un teixit al laboratori. Com ho fan? I per què és important dissenyar la forma d’un teixit viu?
The Institute for Bioengineering of Catalonia (IBEC) marked its 20th anniversary with a special edition of its annual Symposium, under the theme ‘20 years shaping the present and future of medicine with bioengineering’. Over two days, more than 350 members of the IBEC community met in Barcelona to share their work, discuss the latest advances in bioengineering and celebrate two decades of interdisciplinary research at the institute.
Xavier Trepat and his team at the Institute for Bioengineering of Catalonia (IBEC) are key partners in ALIVE: Active Living Matter — Information, Vitality, and Emergence, an international research programme selected for funding through the first European edition of the Novo Nordisk Foundation Challenge Programme. Coordinated by the Niels Bohr Institute in Copenhagen, the project will receive 75 million DKK (around €10 million) over six years to uncover how information flows drive the emergence, organisation and function of living tissues.
Researchers at the Institute for Bioengineering for Catalonia (IBEC), the Polytechnic University of Catalonia – BarcelonaTech (UPC) and the International Centre for Numerical Methods in Engineering (CIMNE) have developed a new strategy for ‘programming’ the shape of biological tissues in vitro. The study, published in the journal Science, is the first to demonstrate that it is possible to guide the forces and final shape of living tissue by controlling the orientation of its cells. The research opens the door to new applications in tissue engineering, biohybrid robotics, and the design of smart living materials.
La inmunoterapia es una alternativa como tratamiento contra el cáncer. Investigadores del Ibec y del Hospital del Mar están desarrollando un dispositivo para mejorar los resultados de estas terapias. Declaraciones de Alexandre Calon, investigador del IMIM-Hospital del Mar; Xavier Trepat, Profesor de investigación ICREA a L’IBEC.